Published in Neurology on April 01, 1995
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology (2012) 2.26
Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry (1998) 1.75
Genetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest. J Genet Couns (2011) 1.01
Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study. J Neurol Neurosurg Psychiatry (1999) 0.83
Parkinson's disease dementia: a diminished role for the Lewy body. Parkinsonism Relat Disord (2009) 0.83
Imaging changes associated with cognitive abnormalities in Parkinson's disease. Brain Struct Funct (2014) 0.81
Chocolate consumption is increased in Parkinson's disease. Results from a self-questionnaire study. J Neurol (2009) 0.81
Behavioral disturbances in Parkinson's disease. Dialogues Clin Neurosci (2004) 0.76
CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report. PLoS One (2016) 0.75
Phenomenology and management of cognitive and behavioral disorders in Parkinson's disease. Rise and logic of dementia in Parkinson's disease. Ann Gen Psychiatry (2006) 0.75
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol (1991) 3.70
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology (2002) 3.57
Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc (1995) 3.51
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 3.14
Restriction in complex activities of daily living in MCI: impact on outcome. Neurology (2006) 2.64
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain (2006) 2.54
A 5-year longitudinal study of the Mini-Mental State Examination in normal aging. Am J Epidemiol (1997) 2.50
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
Health, cognitive, and psychosocial factors as predictors of mortality in an elderly community sample. J Epidemiol Community Health (1999) 2.39
Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry (1999) 2.33
Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. French Cryptococcosis Study Group. Clin Infect Dis (1996) 2.33
Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke (1991) 2.19
Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology (2001) 2.18
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Dietary patterns and risk of dementia: the Three-City cohort study. Neurology (2007) 2.09
A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM. Cephalalgia (1992) 2.05
Case-control study of migraine and risk of ischaemic stroke in young women. BMJ (1995) 2.03
Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol (1994) 1.96
Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol (1991) 1.89
Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care (2001) 1.88
Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology (2004) 1.87
Intake of flavonoids and risk of dementia. Eur J Epidemiol (2000) 1.85
Breathing disorders during sleep and cognitive performance in an older community sample: the EVA Study. J Am Geriatr Soc (1996) 1.83
Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects. Neurology (2004) 1.82
Low blood pressure and risk of depression in the elderly. A prospective community-based study. Br J Psychiatry (2000) 1.80
Migraine and risk of ischaemic stroke: a case-control study. BMJ (1993) 1.79
Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol (1980) 1.78
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) (1997) 1.77
Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry (1998) 1.75
Familial idiopathic cerebral calcifications. J Neurol Neurosurg Psychiatry (1977) 1.75
Modelling age-specific risk: application to dementia. Stat Med (1998) 1.74
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology (2009) 1.70
Normal rates of forgetting of verbal and non-verbal material in Alzheimer's disease. Cortex (1987) 1.68
Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology (1999) 1.67
Components of drinking water and risk of cognitive impairment in the elderly. Am J Epidemiol (1994) 1.64
Long-term prognosis in two forms of childhood epilepsy: typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci. Ann Neurol (1983) 1.64
Body mass index and incidence of dementia: the PAQUID study. Neurology (2003) 1.63
Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol (2007) 1.60
Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet (1998) 1.60
Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting. J Nutr Health Aging (2013) 1.57
Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry (2008) 1.56
Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc (1992) 1.52
Severe impairment battery. A neuropsychological test for severely demented patients. Arch Neurol (1994) 1.51
The Paquid epidemiological program on brain ageing. Neuroepidemiology (1992) 1.51
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
Self-rated health and risk of incident dementia: a community-based elderly cohort, the 3C study. Neurology (2011) 1.50
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology (2005) 1.50
EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease. Neurology (1997) 1.48
Validation of self-reported neurological disability in multiple sclerosis. Int J Epidemiol (1994) 1.48
The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology (2007) 1.47
Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol (1999) 1.45
IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging (2007) 1.44
[The Paquid research program on the epidemiology of dementia. Methods and initial results]. Rev Neurol (Paris) (1991) 1.43
Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group. Clin Infect Dis (1996) 1.42
Effect of smoking on global cognitive function in nondemented elderly. Neurology (2004) 1.42
A penalized likelihood approach for arbitrarily censored and truncated data: application to age-specific incidence of dementia. Biometrics (1998) 1.42
Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol (2001) 1.42
Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors. Arch Neurol (1984) 1.41
Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration. Am J Epidemiol (1996) 1.41
Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors. Neurology (2012) 1.41
Functional impairment in instrumental activities of daily living: an early clinical sign of dementia? J Am Geriatr Soc (1999) 1.40
Initial factors predicting functional performance in patients with traumatic tetraplegia. Paraplegia (1990) 1.40
[Difficulties in differential diagnosis of long-term Creutzfeldt- Jakob disease]. Neurologia (1995) 1.39
Frequency of severe attacks in migraine sufferers of the Gazel cohort. Cephalalgia (1997) 1.38
Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology (2000) 1.36
Dementia case management effectiveness on health care costs and resource utilization: a systematic review of randomized controlled trials. J Nutr Health Aging (2010) 1.36
The alien hand syndrome. Clinical and postmortem findings. Arch Neurol (1989) 1.35
Influence of education on the relationship between white matter lesions and cognition. Neurology (2003) 1.35
Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study. Am J Epidemiol (2000) 1.30
Cognitive process in preclinical phase of dementia. Brain (1998) 1.29
Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology (1999) 1.29
Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid. Am J Epidemiol (1998) 1.25
Self-reported memory complaints and memory performance in elderly French community residents: results of the PAQUID Research Program. Neuroepidemiology (1994) 1.24